BARCA, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 2.576
EU - Europa 2.269
AS - Asia 1.280
SA - Sud America 407
Continente sconosciuto - Info sul continente non disponibili 93
AF - Africa 37
OC - Oceania 2
Totale 6.664
Nazione #
US - Stati Uniti d'America 2.511
RU - Federazione Russa 1.208
SG - Singapore 479
CN - Cina 426
BR - Brasile 352
IE - Irlanda 320
SE - Svezia 276
HK - Hong Kong 125
IT - Italia 110
VN - Vietnam 73
DE - Germania 64
PL - Polonia 64
FR - Francia 61
IN - India 61
FI - Finlandia 58
GB - Regno Unito 45
CA - Canada 21
BD - Bangladesh 18
BE - Belgio 17
ZA - Sudafrica 15
AR - Argentina 14
MX - Messico 14
JP - Giappone 13
TR - Turchia 13
NL - Olanda 12
IQ - Iraq 11
EC - Ecuador 10
ID - Indonesia 10
UA - Ucraina 10
PK - Pakistan 9
CR - Costa Rica 8
VE - Venezuela 8
MA - Marocco 7
UZ - Uzbekistan 7
ES - Italia 6
TH - Thailandia 6
CI - Costa d'Avorio 5
IR - Iran 5
UY - Uruguay 5
CL - Cile 4
CO - Colombia 4
MY - Malesia 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BO - Bolivia 3
DZ - Algeria 3
HN - Honduras 3
KZ - Kazakistan 3
PA - Panama 3
PE - Perù 3
RS - Serbia 3
TN - Tunisia 3
AU - Australia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
IL - Israele 2
MD - Moldavia 2
NI - Nicaragua 2
PH - Filippine 2
PT - Portogallo 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BM - Bermuda 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 6.573
Città #
Moscow 375
Ashburn 325
Dublin 319
Dallas 298
Singapore 264
Chandler 210
San Jose 170
Nyköping 150
Beijing 136
Hong Kong 125
Council Bluffs 67
Dearborn 67
Los Angeles 62
Warsaw 62
Ann Arbor 61
Jacksonville 61
The Dalles 60
Princeton 55
Cambridge 51
Medford 50
Lauterbourg 44
New York 41
Des Moines 40
Munich 24
São Paulo 24
Jinan 23
Messina 23
San Mateo 23
Santa Clara 21
Wilmington 21
Boardman 20
Buffalo 20
Hanoi 19
Shenyang 19
Ho Chi Minh City 18
Houston 18
Tianjin 18
Lancaster 16
Brussels 15
Redondo Beach 15
Chennai 14
Ningbo 14
Rome 14
Atlanta 13
Phoenix 13
Tokyo 13
Nanjing 12
Belo Horizonte 11
Brooklyn 11
Hangzhou 11
Orem 11
Hebei 10
Hyderabad 10
Rio de Janeiro 10
Brasília 9
Bremen 9
Denver 9
Frankfurt am Main 8
Guangzhou 8
Johannesburg 8
Taizhou 8
Turku 8
Campinas 7
Changsha 7
Haikou 7
Manchester 7
Salvador 7
San José 7
Zhengzhou 7
Cagliari 6
Helsinki 6
Jakarta 6
Madurai 6
Pune 6
Washington 6
Abidjan 5
Alvorada 5
Ankara 5
Catania 5
Chicago 5
Düsseldorf 5
Fairfield 5
Haiphong 5
London 5
Manaus 5
Montevideo 5
Naples 5
Norwalk 5
San Francisco 5
Tashkent 5
Asunción 4
Boston 4
Can Tho 4
Curitiba 4
Da Nang 4
Dhaka 4
Dong Ket 4
Florence 4
Hillsboro 4
Las Vegas 4
Totale 3.864
Nome #
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 284
A life threatening case of β-enolase deficiency 211
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 203
Auditory system involvement study in 20 patients with late-onset Pompe disease 195
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 189
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 189
ANT1 is reduced in sporadic inclusion body myositis. 185
A study of auditory system in 20 patients with late onset Pompe disease 182
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 182
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 173
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 172
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 171
Auditory system involvement study in 20 patients with lateonset pompe disease 163
The Role of Mitochondria in Cerebellar Ataxias 158
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 153
CEREBELLAR ATAXIA AND SEVERE MUSCLE CoQ10 DEFICIENCY IN A PATIENT WITH A NOVEL MUTATION IN ADCK3 152
Clinical, morphological and genetic features of a large cohort of late onset GSDII patients: typical and atypical presentation 150
Are there ERT defined guidelines for Pompe disease? 150
ANO10 mutations cause ataxia and coenzyme Q₁₀ deficiency 146
An unusual clinical presentation of Pompe disease charactherized by a severe distal myopathy 142
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 137
CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome 134
Chapter 34 - Primary Cerebellar CoQ10 Deficiency 133
Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway 133
Coinvolgimento muscolare in un caso di sindrome di Sweet (dermatosi neutrofila febbrile) 128
Metabolic Myoglobinuria 128
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients 119
Ruolo patogenetico dei microRNAs nelle calpainopatie 117
The Italian Mitochondrial Registry: design and preliminary results 111
Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy 108
Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum 108
Wound botulism in drug users: a still underestimated diagnosis 104
Muscle imaging findings in GNE myopathy. 103
Late-onset Pompe disease (LOPD): Correlations between respiratory muscles CT and MRI features and pulmonary function 102
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene 99
Differential expression of microRNAs in primary and secondary calpainopathies 98
Quantitative muscle MRI and functional measures in a cohort of late onset GSD II patients 96
Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency 94
Un caso di rabdomiolisi massiva da deficit di β-enolasi 91
Role of the autophagic process in adult-onset patients with Pompe disease 87
Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway 87
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 87
Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes 86
Muscle gene expression profile in adult onset patients with Pompe disease 85
Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation 84
Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency 81
Differential expression of microRNAs in primary and secondary calpainopathies 80
Role of the autophagic process in adult-onset patients with Pompe disease 75
Ruolo del processo autofagico nella forma ad insorgenza adulta di malattia di Pompe 74
Therapeutic approaches in the late onset form of GSD II 73
Update on diagnostics of metabolic myopathies 72
Totale 6.664
Categoria #
all - tutte 22.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022348 0 0 0 25 19 4 35 18 8 67 56 116
2022/2023828 61 86 28 57 60 92 3 48 360 3 25 5
2023/2024206 22 26 21 19 17 37 1 14 1 20 3 25
2024/2025871 13 5 12 41 31 68 2 165 258 58 69 149
2025/20262.988 135 249 246 243 235 615 354 337 353 120 47 54
2026/2027577 54 224 136 163 0 0 0 0 0 0 0 0
Totale 6.664